Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10012538HBVENSG00000057252.13protein_codingSOAT1NoNo6646P35610
TVIS10013403HBVENSG00000057252.13protein_codingSOAT1NoNo6646P35610
TVIS10012539HBVENSG00000057252.13protein_codingSOAT1NoNo6646P35610
TVIS30021119HIVENSG00000057252.13protein_codingSOAT1NoNo6646P35610
TVIS20048100HPVENSG00000057252.13protein_codingSOAT1NoNo6646P35610
TVIS44030650HTLV-1ENSG00000057252.13protein_codingSOAT1NoNo6646P35610
TVIS44037130HTLV-1ENSG00000057252.13protein_codingSOAT1NoNo6646P35610
TCGA Plot Options
Drug Information
GeneSOAT1
DrugBank IDDB00973
Drug NameEzetimibe
Target IDBE0000105
UniProt IDP35610
Regulation Typeinhibitor
PubMed IDs19669185; 20227438; 18442485
CitationsSingh A, Basit A, Banerjee UC: Burkholderia cenocepacia: a new biocatalyst for efficient bioreduction of ezetimibe intermediate. J Ind Microbiol Biotechnol. 2009 Nov;36(11):1369-74. doi: 10.1007/s10295-009-0622-z. Epub 2009 Aug 8.@@Costet P: Molecular pathways and agents for lowering LDL-cholesterol in addition to statins. Pharmacol Ther. 2010 Jun;126(3):263-78. doi: 10.1016/j.pharmthera.2010.02.006. Epub 2010 Mar 19.@@Wang HH, Portincasa P, Mendez-Sanchez N, Uribe M, Wang DQ: Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology. 2008 Jun;134(7):2101-10. doi: 10.1053/j.gastro.2008.03.011. Epub 2008 Mar 10.
GroupsApproved
Direct ClassificationMonobactams
SMILES[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1
Pathways
PharmGKBPA10816
ChEMBLCHEMBL1138